This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eurocare 2. IARC Scientific Publications. 1999;51:1–572.
Ransahoff D. Screening for colorectal cancer. N Engl J Med. 2002;346:40–44.
Atkin W. Screening for colorectal cancer: the heart of the matter. Gut 1999;45:480–481.
Mandel JS, Bond JH, Church TR. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371.
Hardcastle JD, Chamberlain JO, Robinson MHE. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348:1472–1477.
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–1471.
Towler B, Irwig L, Glasziou P. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, haemoccult. BMJ. 1998;317:559–565.
Robinson M, Hardcastle J, Moss S, et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999;45:588–592.
Vasen HFA. High incidence of interval cancers in HNPCC. An update of the Dutch HNPCC registry. Paper presented at: 10th Annual ICG-HNPCC Meeting; June 1998; Portugal.
Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405–1411.
Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal occult blood screening in colorectal cancer. Lancet 1996;348:1472–1477.
Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med. 1993;328:1365–1371.
Winawer SJ, Schottenfield D, Felhinger BJ. Colorectal cancer screening. J Natl Cancer Inst. 1991; 83:243–253.
Atkin WS, Hart A, Edwards R. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998;42:560–565.
Cannon-Albright LA, Thomas TC, Bishop DT, Skolnick MH, Burt RW. Characteristics of familial colon cancer in a large population database. Cancer 1989;64:1971–1975.
Dunlop MG, Farrington SM, Carothers D, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105–110.
Friedl W, Meuschel S, Caspari, et al. Attenuated familial adenomatous polyposis due to a mutation in the 3″ part of the APC gene. Hum Genet. 1996;97:579–584.
UK Flexible Sigmoidoscopy Screening Trial Investigation. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline finding of a UK multicentre randomised trial. Lancet 2002;359: 1291–1300.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag London Limited
About this chapter
Cite this chapter
Scholefield, J.H., Ritchie, S.J. (2005). Screening for Colorectal Cancer. In: Beynon, J., Carr, N.D. (eds) Progress in Colorectal Surgery. Springer, London. https://doi.org/10.1007/1-84628-058-3_2
Download citation
DOI: https://doi.org/10.1007/1-84628-058-3_2
Publisher Name: Springer, London
Print ISBN: 978-1-85233-823-7
Online ISBN: 978-1-84628-058-0
eBook Packages: MedicineMedicine (R0)